Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Goldman

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
The American Journal of Managed Care|August 25, 2022
Continuous glucose monitoring metrics: interpretation and integrationsJennifer Goldman
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Biosimilar and Follow-on Insulin: The Ins, Outs, and InterchangeabilityJohn White, Jennifer Goldman
The Annals of Pharmacotherapy|August 5, 2015
New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes MellitusJennifer Goldman, John R White
The Annals of Pharmacotherapy|June 25, 2017
iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 DiabetesJennifer Goldman, Jennifer M Trujillo
Pharmacotherapy|May 31, 2017
Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 DiabetesJennifer M Trujillo, Jennifer Goldman
American Journal of Infection Control|August 4, 2017
Staff nurses as antimicrobial stewards: An integrative literature reviewElizabeth Monsees, Jennifer Goldman, Lori Popejoy
The Annals of Pharmacotherapy|October 19, 2024
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes ManagementJennifer Goldman, Curtis Triplitt, Diana Isaacs
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2017
Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 DiabetesVirginia Valentine, Jennifer Goldman, Jay H Shubrook
American Journal of Infection Control|July 10, 2020
Implementation of a nurse-driven antibiotic engagement tool in 3 hospitalsElizabeth Monsees, Brian Lee, Anne Wirtz, et al.
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
The American Journal of Managed Care|August 25, 2022
Continuous glucose monitoring metrics: interpretation and integrationsJennifer Goldman
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|December 3, 2021
Biosimilar and Follow-on Insulin: The Ins, Outs, and InterchangeabilityJohn White, Jennifer Goldman
The Annals of Pharmacotherapy|August 5, 2015
New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes MellitusJennifer Goldman, John R White
The Annals of Pharmacotherapy|June 25, 2017
iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 DiabetesJennifer Goldman, Jennifer M Trujillo
Pharmacotherapy|May 31, 2017
Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 DiabetesJennifer M Trujillo, Jennifer Goldman
American Journal of Infection Control|August 4, 2017
Staff nurses as antimicrobial stewards: An integrative literature reviewElizabeth Monsees, Jennifer Goldman, Lori Popejoy
The Annals of Pharmacotherapy|October 19, 2024
Icodec: A Novel Once-Weekly Basal Insulin for Diabetes ManagementJennifer Goldman, Curtis Triplitt, Diana Isaacs
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2017
Rationale for, Initiation and Titration of the Basal Insulin/GLP-1RA Fixed-Ratio Combination Products, IDegLira and IGlarLixi, for the Management of Type 2 DiabetesVirginia Valentine, Jennifer Goldman, Jay H Shubrook
American Journal of Infection Control|July 10, 2020
Implementation of a nurse-driven antibiotic engagement tool in 3 hospitalsElizabeth Monsees, Brian Lee, Anne Wirtz, et al.
Current Medical Research and Opinion|May 25, 2017
Understanding how pharmacokinetic and pharmacodynamic differences of basal analog insulins influence clinical practiceJennifer Goldman, Christoph Kapitza, Jeremy Pettus, et al.
Pageof 6